Enhancing health and well-being
Behandlung is health company committed with clear purpose to deliver better everyday health and well-being.
Behandlung pharma objective is enhancing health and wellbeing for consumers all around the world
Behandlung pharma strategic approaches
Achievement of our objective needs significant increase in our consumer adoption rate and users along with launching powerful brands.
Deep human understanding
We invest in a portfolio of proprietary assets to obtain a comprehensive understanding of human needs and aspirations, with the aim of enhancing daily activities and health outcomes.
Trusted science & Innovation
Developing advanced science-based solutions through a comprehensive understanding of consumer needs and aspirations. We leverage the technical and scientific expertise that comes from our scientists with strong regulatory understanding. We continue to invest in research and development (R&D) to support our innovation.
Business excellence
Behandlung Pharma is dedicated to achieving exceptional results for stakeholders through the implementation of exemplary organizational practices and daily operations in areas such as commercial, marketing, and operational activities. These efforts are grounded in a set of core concepts and values that are deeply embedded in our culture. Business excellence models by Behandlung pharma will help to outstanding stakeholder-results along with high productivity, competitiveness, and sustainability.
Full Potential People
Our team is our greatest asset and key to achieving our goals.
We are committed to unlocking our team's potential and motivating them to achieve their goals and align with corporate objectives.
Leadership
Moving toward success, together
Our Board oversees both the long- and short-term success of Behandlung. They are accountable for the corporate governance system, strategy, activities, financial performance, and risk management of the Group.
Samanth pateel
Chief executive officer
Javi Roderiguiz
Chief commercial officer
Mei Ling
Chief marketing
Mohamed Mahgoub
Middle east CEO
Wesam Al Zaky
Chief operation officer